Full Text AA-96-002 ANTIBODIES AND ALCOHOL-RELATED BEHAVIOR NIH GUIDE, Volume 25, Number 10, March 29, 1996 RFA: AA-96-002 P.T. 34 Keywords: Alcohol/Alcoholism Neurotransmitters Receptors National Institute on Alcohol Abuse and Alcoholism Letter of Intent Receipt Date: May 13, 1996 Application Receipt Date: June 13, 1996 PURPOSE The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks research applications aimed at developing antibodies to proteins mediating alcohol-related behaviors. This Request for Applications (RFA) invites research applications that develop and utilize such antibodies to study the effects of ethanol on neurotransmitter receptor subtypes and second messenger proteins and on phosphorylation states involved in the actions of ethanol. Applications should develop and characterize highly specific antibodies to determine the distribution of the subunits in specific cell types, neural pathways, and brain regions known for their ethanol sensitivity. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This RFA, Antibodies and Alcohol-Related Behavior, is related to the priority areas of alcohol abuse reduction and alcoholism treatment. Potential applicants may obtain a copy of "Healthy People 2000" (Full Report: Stock No. 017-001-00474-0 or Summary Report: Stock No. 017-001-00473-1) through the Superintendent of Documents, Government Printing Office, Washington, D.C. 20402-9325 (Telephone: 202-512-1800). ELIGIBILITY Applications may be submitted by domestic and foreign, for-profit and non-profit, public and private organizations, such as universities, colleges, hospitals, laboratories, units of State and local governments, and eligible agencies of the Federal government. Racial/ethnic minority individuals, women, and persons with disabilities are encouraged to apply as Principal Investigators. MECHANISM OF SUPPORT Research support may be obtained through applications for a regular research project grant (R01) for up to five years. In FY 1995, the average total cost per year for new R01s funded by NIAAA was approximately $200,000. Because the nature and scope of the research proposed in response to this RFA may vary, it is anticipated that the size of an award will vary also. Program project grant applications (P01) will not be accepted for this RFA. Applicants may submit applications for Investigator-Initiated Interactive Research Project Grants (IRPGs). Interactive Research Project Grants require the coordinated submission of related research project grant (R01) and, to a limited extent FIRST Award (R29) applications from investigators who wish to collaborate on research, but do not require extensive shared physical resources. These applications must share a common theme and describe the objectives and scientific importance of the interchange of, for example, ideas, data, and materials among the collaborating investigators. A minimum of two independent investigators with related research objectives may submit concurrent, collaborative, cross-referenced individual R01 and R29 applications. Applicants may be from one or several institutions. Further information on these and other grant mechanisms may be obtained from the program staff listed under INQUIRIES. Further information on the IRPG mechanism is available in program announcement PA-96-001, NIH Guide for Grants and Contracts, Vol. 24, No. 35, October 6, 1995. FUNDS AVAILABLE It is estimated that up to $1.4 million will be available for approximately six to seven grants under this RFA in FY 1996. This level of support is dependent on the receipt of sufficient number of applications of high scientific merit. Although this program is provided for in the financial plan of NIAAA, the award of grants pursuant to this RFA is also contingent upon the availability of funds for this purpose. The earliest possible award date is September 30, 1996. RESEARCH OBJECTIVES Alcohol has the unique characteristic of being a very simple water- soluble molecule that interacts with specific hydrophobic domains of important proteins to alter their normal function. Such actions of alcohol on single molecules perturb the inter- and intracellular signaling systems containing those molecules and thereby exert diverse and profound effects on neural responses. As a result, ethanol is known to alter the activity of a variety of processes involved in synaptic transmission. Many studies indicate that ethanol acts directly on neurotransmitter receptors and second messenger proteins, thereby altering the normal neuronal activity. Proteins of interest include gamma-aminobutyric acid (GABA), glutamate (both the NMDA and AMPA types), serotonin, and dopamine receptors and cyclases, G-proteins, and protein kinases involved in signal transduction. Many of the proteins affected by ethanol are complex macromolecular proteins with numerous subtypes containing multiple subunits. Some protein assemblies are more sensitive to ethanol than others, such as observed for GABA and NMDA receptors. It is hypothesized that the subunit composition of the receptors in the brain is important in determining ethanol sensitivity. Unfortunately, sufficient probes are not available for studying all of the subunits and in sufficient quantities to make progress in determining the influence of each subunit in different regions of the brain. In addition, the phosphorylation state of the protein may be of crucial importance in the actions of ethanol on the protein. Knowing the specific receptor subtypes and phosphorylation states involved in ethanol actions, especially the distribution of the subunits and subtypes in specific nuclei, neural pathways, and brain regions known for their alcohol sensitivity, will provide a basis for rational medications development for treatment of ethanol-induced behaviors. Applications are encouraged to develop and produce antibodies as probes for identifying subunits of relevant ethanol-affected proteins in the brain that are not presently available or only in limited quantities. Applicants may undertake the development of specific antibodies or utilize antibodies obtained through subcontracts in exploring the properties of specified neuronal proteins. Applications should provide a means of producing the antibodies, as well as propose measures to ensure quality control, including specificity and cross-reactivity of the products. In addition, applicants are encouraged to develop monoclonal versions of the antibodies, to ensure batch-to-batch uniformity. SPECIAL REQUIREMENTS Since a purpose of this RFA is to provide unique sets of antibodies to NIAAA-funded researchers who are unable to obtain them for themselves, antibodies developed in this initiative should be made available to other investigators by an approved distribution plan in accordance with the "NIAAA Policy on Distribution of Unique Research Resources Produced with NIAAA Funding," and the PHS Policy Relating to Distribution of Unique Research Resources Produced with PHS Funding (NIH Guide, Volume 23, Number 26, July 15, 1994). Indication of the intent to comply with these policies will be considered in the Institute's award decisions. LETTER OF INTENT Prospective applicants are asked to submit, by May 13, 1996, a letter of intent that includes a descriptive title of the proposed research, the name, address, and telephone number of the Principal Investigator, the identities of other key personnel and participating institutions, and the number of title of the RFA in response to which the application may be submitted. Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows NIAAA staff to estimate the potential review workload and avoid conflict of interest in the review. The letter of intent is to be sent to: RFA-AA-96-002 Office of Scientific Affairs National Institute on Alcohol Abuse and Alcoholism Willco Building, Suite 409 6000 Executive Boulevard MSC 7003 Bethesda, MD 20892-7003 FAX: (301) 443-6077 APPLICATION PROCEDURES The research grant application form PHS 398 (rev. 5/95) is to be used in applying for these grants. Applications kits are available at most institutional offices of sponsored research and may be obtained from the Grants Information Office, Office of Extramural Outreach and Information Resources, National Institutes of Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, telephone 301/710-0267, email: ASKNIH@odrockm1.od.nih.gov; and from NIAAA staff listed under INQUIRIES. The RFA label available in the PHS 398 (rev. 5/95) application form must be affixed to the bottom of the face page of the application. Failure to use this label could result in delayed processing of the application such that it may not reach the review committee in time for review. In addition, the RFA title and number must be typed on line 2 of the face page of the application form and the YES box must be marked. Page limits and limits on size of type are strictly enforced. Non-conforming applications will be returned without being reviewed. Submit a signed, typewritten original of the application, including the checklist and three signed photo copies in one package to: DIVISION OF RESEARCH GRANTS NATIONAL INSTITUTES OF HEALTH 6701 ROCKLEDGE DRIVE, ROOM 1040 - MSC 7710 BETHESDA, MD 20892-7710 BETHESDA, MD 20817 (for express/courier service) At the time of submission, two additional copies of the application must also be sent to: RFA AA-96-002 Office of Scientific Affairs National Institute on Alcohol Abuse and Alcoholism Willco Building, Room 409 6000 Executive Boulevard, MSC 7003 Bethesda, MD 20892-7003 Rockville, MD 20852 (for express/courier service) FAX: (301) 443-6077 Failure to forward the above two applications to NIAAA at the above address may delay consideration of an application such that it may not be received in time for FY 1996 funding consideration. Applications must be received by June 13, 1996. If an application is received after that date, it will be returned to the applicant without review. The Division of Research Grants (DRG) will not accept any application in response to this RFA that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. The DRG will not accept any application that is essentially the same as one already reviewed. This does not preclude the submission of substantial revisions of applications already reviewed, but such applications must include an introduction addressing the previous critique. REVIEW CONSIDERATIONS Upon receipt, applications will be reviewed for completeness by DRG and for responsiveness by the NIAAA. Incomplete applications will be returned to the applicant without further consideration. If the application is not responsive to the RFA, DRG staff may contact the applicant to determine whether to return the application to the applicant or submit it for review in competition with unsolicited applications at the next review cycle. Applications that are complete and responsive to the RFA will be evaluated for scientific and technical merit by an appropriate peer review group convened by the NIAAA in accordance with the review criteria stated below. As part of the initial merit review, all applications will receive a written critique and undergo a process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed, assigned a priority score, and receive a second level review by the appropriate national advisory council or board. The second level of review will be provided by the National Advisory Council on Alcohol Abuse and Alcoholism. Review Criteria Criteria to be used in the scientific and technical merit review of the research grant applications will include the following: 1. The scientific, technical, or medical significance and originality of the proposed research. 2. The appropriateness and adequacy of the experimental approach and methodology, including adequacy of quality control methods, proposed to carry out the research. 3. The adequacy of the qualifications (including level of education and training) and relevant research experience of the principal investigator and key research personnel. 4. The availability of adequate facilities, general environment for the conduct of the proposed research, other resources, and collaborative arrangements necessary for the research. 5. The reasonableness of budget estimates and duration for the proposed research. 6. Where applicable, the adequacy of procedures to protect or minimize effects on animal subjects and the environment. AWARD CRITERIA Applications recommended for approval by the National Advisory Council on Alcohol Abuse and Alcoholism will be considered for funding on the basis of the overall scientific and technical merit of the application as determined by peer review, NIAAA programmatic needs and balance, adequacy of plans for sharing antibodies with other investigators, and the availability of funds. INQUIRIES Potential applicants are strongly encouraged to seek preapplication consultation, for which purpose they may contact the individuals listed below. Direct inquiries regarding the proposed research to: Walter A. Hunt, Ph.D. Division of Basic Research National Institute on Alcohol Abuse and Alcoholism 6000 Executive Boulevard MSC 7003 Bethesda, MD 20892-7003 Telephone: (301) 443-4223 FAX: (301) 594-0673 Email: whunt@willco.niaaa.nih.gov Direct inquiries regarding fiscal matters to: Joseph Weeda Office of Planning and Resource Management National Institute on Alcohol Abuse and Alcoholism 6000 Executive Boulevard MSC 7003 Bethesda, MD 20892-7003 Telephone: (301) 443-4703 FAX: (301) 443-3891 Email: jweeda@willco.niaaa.nih.gov AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance, No. 93.273. Awards are made under the authorization of the Public Health Service Act, Sections 301 and 464H, and administered under the PHS policies and Federal Regulations at Title 42 CFR Part 52, "Grants for Research Projects;" Title 45 CFR Parts 74 and 92, "Administration of Grants;" and 45 CFR Part 46, "Protections of Human Subjects." This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency Review. The PHS strongly encourages all grant recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people. .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |